Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
35.91
+2.64 (7.94%)
Dec 20, 2024, 4:00 PM EST - Market closed
Tandem Diabetes Care Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 854.35 | 747.72 | 801.22 | 702.8 | 498.83 | 362.31 | Upgrade
|
| Revenue Growth (YoY) | 10.75% | -6.68% | 14.00% | 40.89% | 37.68% | 97.05% | Upgrade
|
| Cost of Revenue | 428.94 | 380.03 | 388.23 | 326.58 | 238.31 | 168.09 | Upgrade
|
| Gross Profit | 425.41 | 367.69 | 412.99 | 376.22 | 260.52 | 194.21 | Upgrade
|
| Selling, General & Admin | 383.22 | 349.79 | 335.67 | 261.51 | 204.9 | 165.74 | Upgrade
|
| Research & Development | 189.28 | 169.67 | 139.11 | 92.05 | 63.57 | 45.2 | Upgrade
|
| Operating Expenses | 572.5 | 519.46 | 474.78 | 353.56 | 268.48 | 210.93 | Upgrade
|
| Operating Income | -147.09 | -151.77 | -61.8 | 22.65 | -7.96 | -16.72 | Upgrade
|
| Interest Expense | -7.36 | -9.88 | -6.21 | -6.04 | -12.81 | - | Upgrade
|
| Interest & Investment Income | 22.7 | 21.2 | 6.06 | 0.67 | 1.57 | 3.19 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.5 | 1.5 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -3.17 | 0.16 | 0.15 | -1.39 | -17.09 | -11.08 | Upgrade
|
| EBT Excluding Unusual Items | -135.41 | -138.79 | -61.8 | 15.9 | -36.28 | -24.6 | Upgrade
|
| Merger & Restructuring Charges | -2.7 | -2.7 | - | - | - | - | Upgrade
|
| Asset Writedown | 14.08 | -0.01 | -0.01 | - | - | - | Upgrade
|
| Other Unusual Items | 0.83 | - | - | - | - | - | Upgrade
|
| Pretax Income | -123.2 | -220.25 | -92.85 | 15.9 | -36.28 | -24.6 | Upgrade
|
| Income Tax Expense | 3.59 | 2.36 | 1.74 | 0.34 | -1.9 | 0.15 | Upgrade
|
| Net Income | -126.78 | -222.61 | -94.59 | 15.57 | -34.38 | -24.75 | Upgrade
|
| Net Income to Common | -126.78 | -222.61 | -94.59 | 15.57 | -34.38 | -24.75 | Upgrade
|
| Shares Outstanding (Basic) | 65 | 65 | 64 | 63 | 61 | 59 | Upgrade
|
| Shares Outstanding (Diluted) | 65 | 65 | 64 | 64 | 61 | 59 | Upgrade
|
| Shares Change (YoY) | 0.91% | 1.28% | -0.32% | 5.51% | 4.24% | 21.56% | Upgrade
|
| EPS (Basic) | -1.94 | -3.43 | -1.47 | 0.25 | -0.56 | -0.42 | Upgrade
|
| EPS (Diluted) | -1.94 | -3.43 | -1.47 | 0.24 | -0.56 | -0.42 | Upgrade
|
| Free Cash Flow | -15.07 | -58.61 | 16.37 | 97.18 | -2.74 | 22.37 | Upgrade
|
| Free Cash Flow Per Share | -0.23 | -0.90 | 0.26 | 1.51 | -0.04 | 0.38 | Upgrade
|
| Gross Margin | 49.79% | 49.17% | 51.54% | 53.53% | 52.23% | 53.60% | Upgrade
|
| Operating Margin | -17.22% | -20.30% | -7.71% | 3.22% | -1.60% | -4.62% | Upgrade
|
| Profit Margin | -14.84% | -29.77% | -11.81% | 2.21% | -6.89% | -6.83% | Upgrade
|
| Free Cash Flow Margin | -1.76% | -7.84% | 2.04% | 13.83% | -0.55% | 6.17% | Upgrade
|
| EBITDA | -130.7 | -136.05 | -47.47 | 36.5 | 2.49 | -10.65 | Upgrade
|
| EBITDA Margin | -15.30% | -18.20% | -5.92% | 5.19% | 0.50% | -2.94% | Upgrade
|
| D&A For EBITDA | 16.39 | 15.72 | 14.33 | 13.85 | 10.45 | 6.07 | Upgrade
|
| EBIT | -147.09 | -151.77 | -61.8 | 22.65 | -7.96 | -16.72 | Upgrade
|
| EBIT Margin | -17.22% | -20.30% | -7.71% | 3.22% | -1.60% | -4.62% | Upgrade
|
| Effective Tax Rate | - | - | - | 2.11% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.